BIOMAT Database Logo BIOMAT Database Logo

Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death. 1999

B Herbert, and A E Pitts, and S I Baker, and S E Hamilton, and W E Wright, and J W Shay, and D R Corey
Department of Cell Biology, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75235, USA.

The correlation between telomerase activity and human tumors has led to the hypothesis that tumor growth requires reactivation of telomerase and that telomerase inhibitors represent a class of chemotherapeutic agents. Herein, we examine the effects of inhibition of telomerase inside human cells. Peptide nucleic acid and 2'-O-MeRNA oligomers inhibit telomerase, leading to progressive telomere shortening and causing immortal human breast epithelial cells to undergo apoptosis with increasing frequency until no cells remain. Telomere shortening is reversible: if inhibitor addition is terminated, telomeres regain their initial lengths. Our results validate telomerase as a target for the discovery of anticancer drugs and supply general insights into the properties that successful agents will require regardless of chemical type. Chemically similar oligonucleotides are in clinical trials and have well characterized pharmacokinetics, making the inhibitors we describe practical lead compounds for testing for an antitelomerase chemotherapeutic strategy.

UI MeSH Term Description Entries
D009841 Oligonucleotides Polymers made up of a few (2-20) nucleotides. In molecular genetics, they refer to a short sequence synthesized to match a region where a mutation is known to occur, and then used as a probe (OLIGONUCLEOTIDE PROBES). (Dorland, 28th ed) Oligonucleotide
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D016615 Telomere A terminal section of a chromosome which has a specialized structure and which is involved in chromosomal replication and stability. Its length is believed to be a few hundred base pairs. Telomeres
D016923 Cell Death The termination of the cell's ability to carry out vital functions such as metabolism, growth, reproduction, responsiveness, and adaptability. Death, Cell
D019098 Telomerase An essential ribonucleoprotein reverse transcriptase that adds telomeric DNA to the ends of eukaryotic CHROMOSOMES. Telomerase Catalytic Subunit,Telomerase Reverse Transcriptase,Telomerase Reverse Transcriptase Catalytic Subunit,Catalytic Subunit, Telomerase,Reverse Transcriptase, Telomerase,Subunit, Telomerase Catalytic,Transcriptase, Telomerase Reverse
D020135 Peptide Nucleic Acids DNA analogs containing neutral amide backbone linkages composed of aminoethyl glycine units instead of the usual phosphodiester linkage of deoxyribose groups. Peptide nucleic acids have high biological stability and higher affinity for complementary DNA or RNA sequences than analogous DNA oligomers. Peptide Nucleic Acid,Acid, Peptide Nucleic,Acids, Peptide Nucleic,Nucleic Acid, Peptide,Nucleic Acids, Peptide

Related Publications

B Herbert, and A E Pitts, and S I Baker, and S E Hamilton, and W E Wright, and J W Shay, and D R Corey
Estrogen deficiency leads to telomerase inhibition, telomere shortening and reduced cell proliferation in the adrenal gland of mice.
November 2008, Cell research,
B Herbert, and A E Pitts, and S I Baker, and S E Hamilton, and W E Wright, and J W Shay, and D R Corey
Nanoparticle mediated delivery of 2'-O-methyl-RNA leads to efficient telomerase inhibition and telomere shortening in human lung cancer cells.
June 2010, Lung cancer (Amsterdam, Netherlands),
B Herbert, and A E Pitts, and S I Baker, and S E Hamilton, and W E Wright, and J W Shay, and D R Corey
Telomere elongation in immortal human cells without detectable telomerase activity.
September 1995, The EMBO journal,
B Herbert, and A E Pitts, and S I Baker, and S E Hamilton, and W E Wright, and J W Shay, and D R Corey
Telomere length dynamics in telomerase-positive immortal human cell populations.
March 1998, Experimental cell research,
B Herbert, and A E Pitts, and S I Baker, and S E Hamilton, and W E Wright, and J W Shay, and D R Corey
Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity.
May 1992, The EMBO journal,
B Herbert, and A E Pitts, and S I Baker, and S E Hamilton, and W E Wright, and J W Shay, and D R Corey
Progressive telomere shortening and telomerase reactivation during hepatocellular carcinogenesis.
January 1997, Cancer genetics and cytogenetics,
B Herbert, and A E Pitts, and S I Baker, and S E Hamilton, and W E Wright, and J W Shay, and D R Corey
Telomere shortening and apoptosis in telomerase-inhibited human tumor cells.
September 1999, Genes & development,
B Herbert, and A E Pitts, and S I Baker, and S E Hamilton, and W E Wright, and J W Shay, and D R Corey
The telomerase inhibitor telomestatin induces telomere shortening and cell death in Arabidopsis.
January 2006, Biochimica et biophysica acta,
B Herbert, and A E Pitts, and S I Baker, and S E Hamilton, and W E Wright, and J W Shay, and D R Corey
Telomerase inhibition, telomere shortening, and senescence of cancer cells by tea catechins.
August 1998, Biochemical and biophysical research communications,
B Herbert, and A E Pitts, and S I Baker, and S E Hamilton, and W E Wright, and J W Shay, and D R Corey
Mechanism of acridine-based telomerase inhibition and telomere shortening.
September 2007, Biochemical pharmacology,
Copied contents to your clipboard!